Condition
Locally Advanced Rectal Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Locally Advanced Rectal Carcinoma clinical trials that are recruiting, at sites in 5 countries (most in China (3), Netherlands (2), United Kingdom (1)). By phase: Phase 3 (2), Phase 2 (2), Early Phase 1 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 5Countries
Newest Locally Advanced Rectal Carcinoma clinical trials
All recruiting trials (8)
-
Triplet vs doublet induction therapy with chemoradiotherapy for high-risk locally advanced rectal cancer, followed by surgery or watch-and-wait
This trial tests whether a triplet induction chemotherapy (FOLFOXIRI) before chemoradiotherapy improves response and long-term outcomes in high-risk locally advanced rectal cancer compared with a doublet induction (CAPOX/FOLFOX).
-
Adding modulated electro‑hyperthermia to total neoadjuvant therapy for locally advanced rectal cancer
This trial tests whether adding modulated electro‑hyperthermia (mEHT) to total neoadjuvant therapy helps adults with locally advanced rectal cancer achieve more tumor down‑staging and higher rates of complete pathological response.
-
Combining chemoradiotherapy with immunotherapy for advanced rectal cancer
This study is testing whether adding an immunotherapy drug to standard treatment can help people with advanced rectal cancer feel better and improve their quality of life.
-
Exercise to enhance chemoradiotherapy effectiveness in advanced rectal cancer patients
This study is testing if an 11-week exercise program can help people with advanced rectal cancer get better results from their chemoradiotherapy treatment.
-
Comparing two methods for preserving organs in rectal cancer patients
This study is testing two different ways to treat rectal cancer in patients who responded well to initial treatment, to see which method helps them keep their organs and improve their quality of life.
-
Neoadjuvant treatment for locally advanced rectal cancer using Serplulimab, CAPEOX, and Celecoxib
This study is testing a new treatment combining an immune therapy and chemotherapy to see if it can help people with locally advanced rectal cancer before surgery.
-
Using circulating tumor DNA to guide treatment for advanced rectal cancer
This study is testing if using a blood test to check for tumor DNA can help doctors give better treatment to people with advanced rectal cancer by personalizing their therapy based on their risk of recurrence.
-
Short course radiation therapy combined with chemotherapy for stage II-III rectal cancer
This study is testing a new treatment plan that combines short radiation therapy with chemotherapy to see if it helps people with stage II-III rectal cancer feel better and have fewer problems after treatment.
Related topics
Quick answers
How many Locally Advanced Rectal Carcinoma clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (3 trials), Netherlands (2 trials), United Kingdom (1 trial), United States (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 2, Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.